The FDA issued updates regarding drugs that are currently in shortage or have been discontinued:
- Amlodipine Besylate and Benazepril Hydrochloride Capsules (New – Discontinuation)
- Amlodipine Besylate Tablets (New – Discontinuation)
- Atropine Sulfate Injection (Updated – Currently in Shortage)
- Calcium Gluconate Injection (Currently in Shortage)
- Cefotetan Disodium Injection (Updated – Currently in Shortage)
- Dextrose 5% Injection Bags (Updated – Currently in Shortage)
- Estropipate Tablets (New – Discontinuation)
- Folic Acid Injection (Updated – Currently in Shortage)
- Hydromorphone Hydrochloride Injection, USP (Updated – Currently in Shortage)
- Imipenem and Cilastatin for Injection, USP (Updated – Currently in Shortage)
- Leucovorin Calcium Lyophilized Powder for Injection (Updated – Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated – Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine (Updated – Currently in Shortage)
- Methylprednisolone Sodium Succinate for Injection, USP (Updated – Currently in Shortage)
- Metoclopramide Injection, USP (Updated – Currently in Shortage)
- Midodrine HCl Tablets (New – Discontinuation)
- Montelukast Sodium Tablets (New – Discontinuation)
- Morphine Sulfate Injection, USP (Currently in Shortage)
- Nabumetone Tablets (New – Discontinuation)
- Penicillamine Tablets (New – Currently in Shortage)
- Phosphate Injection Products (New – Currently in Shortage)
- Piperacillin and Tazobactam (Zosyn) Injection (Updated – Currently in Shortage)
- Potassium Chloride Injection (Updated – Currently in Shortage)
- Rocuronium Bromide Injection (Updated – Currently in Shortage)
- Sodium Chloride 0.9% Injection Bags (Updated – Currently in Shortage)
- Sodium Chloride 23.4% Injection (Updated – Currently in Shortage)
- Sodium Phosphate Injection (Updated – Currently in Shortage)
- Technetium Tc99m Succimer Injection (DMSA) (Updated – Currently in Shortage)
According to the FDA:
“A drug receives Resolved status when the Drug Shortages Staff (DSS) determines that the market is covered, based on information from all manufacturers. The market is considered covered when supply is available from at least one manufacturer to cover total market demand. However, some manufacturers may not have all presentations available. DSS monitors the supply of products with Resolved status. For the most current supply information, contact the manufacturers.”
(Source: U.S. Food & Drug Adminstration)
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
